Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by applying microwave and RF energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical advanced energy platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides clinicians with flexible, accurate and controlled surgical solutions which are safer, less-invasive and more cost-efficient, as well as offering improved patient outcomes (shorter procedures, hospital stays and recovery times).
The Company's strategy is to bring its CROMA platform to market through a suite of medical devices which the Company has designed. Creo's Speedboat device is the first product approved in this suite of tools for minimally invasive surgery. Early applications focus initially on the emerging field of GI therapeutic endoscopy, an area with high unmet needs, but the CROMA platform will be developed further for bronchoscopy and laparoscopy procedures. The CROMA platform and Speedboat have both CE Mark accreditation and FDA 510(k) clearance.